Antibodies News and Research

RSS

Research examines processes of lung scarring and chronic rejection of organ after transplantation

Two new papers examine the processes of lung scarring and chronic rejection of the organ after transplantation, and potential therapies to stop the graft, or transplanted organ and its tissue, from failing.

17 Dec 2020

Researchers are developing new criteria for clinical research of antiphospholipid syndrome

An international team of more than 80 collaborators led by Hospital for Special Surgery (HSS) investigators is developing new classification criteria for clinical research of antiphospholipid syndrome (APS), a life-threatening autoimmune clotting disorder.

17 Dec 2020

Regulating fas protein may be a route to prevent cancer relapse after immunotherapy

Mount Sinai researchers have solved one of the enduring mysteries of cancer immunotherapy: Why does it completely eliminate tumors in many patients, even when not all the cells in those tumors have the molecular target that the therapy is aimed at?

17 Dec 2020

High presence of SARS-CoV-2 nucleic acid in PCR test can predict future symptomatic disease

A new study by researchers at the Karolinska University Hospital in Sweden shows that testing for the presence of SARS-CoV-2 nucleic acid can help in containing the virus spread. Detecting the presence of high amounts of SARS-CoV-2 nucleic acid predicts future symptomatic disease, they found.

17 Dec 2020

SARS-CoV-2 spike deletion ΔH69/ΔV70 shows repeated emergence and spread

Since the COVID 19 pandemic, it has been established that the causative virus, SARS-CoV-2 gains entry to the target host cell via its spike glycoprotein.

17 Dec 2020

HDL nanoparticles prevent cholesterol movement at membrane receptor to inhibit entry of SARS-CoV-2 pseudovirus in cell culture

As researchers strive to find safe therapeutics for COVID 19, a study suggests that preventing the movement of cholesterol may inhibit viral entry by up to 80%.

17 Dec 2020

Scientists develop new vaccine to counter the effects of synthetic cannabinoids

Made in clandestine laboratories and sold widely across the United States, the diverse class of drugs known as synthetic cannabinoids presents a growing public health threat.

17 Dec 2020

Scientists demonstrate a promising strategy for treating lymphomas

Scientists at Scripps Research have demonstrated a promising new strategy for treating lymphomas, a group of cancers that begin in infection-fighting cells of the immune system called lymphocytes.

16 Dec 2020

NET study: New theranostic approach effective in reducing tumor volume and extending lifespan

A pair of copper radionuclides that target the somatostatin receptor overexpressed in neuroendocrine tumors has proven successful in identifying tumors and improving survival.

16 Dec 2020

Potency of neutralizing antibodies predicts COVID-19 severity and survival

Understanding the body's immune response to SARS-CoV-2, the virus that causes COVID-19, is key to developing effective treatments and long-lasting vaccines.

16 Dec 2020

$3.7 million NIH grant supports development of biosensor technology for diagnosing viral diseases

For over ten years, Ali Yanik has been working to develop novel biosensor technology to provide rapid, low-cost testing for disease diagnostics and precision medicine.

16 Dec 2020

LRA survey: Two-thirds of people with lupus are willing to take COVID-19 vaccine

Two out of three people with lupus (64%) are willing to take a COVID-19 vaccine if it is free and determined safe by scientists according to results of a survey conducted by the Lupus Research Alliance.

16 Dec 2020

Traditional herbal medicine Respiratory Detox Shot (RDS) inhibits SARS-CoV, SARS-CoV-2 and Influenza A infection in vitro

As researchers continue to search for antivirals to counter COVID-19, a study presents the potential utility of a decoction called Respiratory Detox Shot (RDS).

16 Dec 2020

Azithromycin trial fails to provide evidence of benefit in COVID-19

Early on in the COVID-19 pandemic, azithromycin was regarded as being a potentially highly effective drug against the virus that causes it, SARS-CoV-2.

16 Dec 2020

AI-based study of social media maps SARS-CoV-2 vaccine hesitancy across the US

Researchers from the University of Rochester, USA, has produced an AI-based study that analyzes the social media platform Twitter to gauge public opinions in the US surrounding SARS-CoV-2 vaccines to shed greater light on this issue.

15 Dec 2020

Could wastewater surveillance help track SARS-COV-2 community outbreaks?

A team of US-based researchers recently conducted an illuminating study that explores this method and its potential uses. In doing so, they have underscored the potential utility of wastewater surveillance in managing SARS-CoV-2 outbreaks.

15 Dec 2020

Tumor's stiff-arm tactic limits the effectiveness of immunotherapeutics

In a paper just published in the Journal for the Immunotherapy of Cancer (doi:10.1136/jitc-2020-001712), Dr Herbert, Head of Discovery at InsideOutBio, asks whether cancer cells stiff-arm immune cells just like rugby players push off defenders from the other team.

15 Dec 2020

Trump’s wrong. 15% ‘herd immunity’ is not on par with strength of a vaccine

During a Dec. 8 press conference about Operation Warp Speed, President Donald Trump likened the spread of the coronavirus throughout the population — which experts agree bestows some immunity on the people who became ill — to having a COVID-19 vaccine.

15 Dec 2020

Structural inequalities in Brazil linked to higher COVID-19-related mortality in low-income areas

A team of researchers aimed to determine the differential health effects of COVID-19 on disadvantaged population groups. They found that low-income and Black and Pardo communities in the country are more likely to die from COVID-19.

15 Dec 2020

Researchers develop new technology for efficient production of monoclonal antibodies

Proteins in biopharmaceutical productions are usually separated and purificated through the expensive chromatography technique. European researchers are developing an innovative membrane crystallization technology to overcome the issue and make the production of monoclonal antibodies more efficient.

15 Dec 2020

Antibodies News and Research

Research examines processes of lung scarring and chronic rejection of organ after transplantation

Researchers are developing new criteria for clinical research of antiphospholipid syndrome

Regulating fas protein may be a route to prevent cancer relapse after immunotherapy

High presence of SARS-CoV-2 nucleic acid in PCR test can predict future symptomatic disease

SARS-CoV-2 spike deletion ΔH69/ΔV70 shows repeated emergence and spread

HDL nanoparticles prevent cholesterol movement at membrane receptor to inhibit entry of SARS-CoV-2 pseudovirus in cell culture

Scientists develop new vaccine to counter the effects of synthetic cannabinoids

Scientists demonstrate a promising strategy for treating lymphomas

NET study: New theranostic approach effective in reducing tumor volume and extending lifespan

Potency of neutralizing antibodies predicts COVID-19 severity and survival

$3.7 million NIH grant supports development of biosensor technology for diagnosing viral diseases

LRA survey: Two-thirds of people with lupus are willing to take COVID-19 vaccine

Traditional herbal medicine Respiratory Detox Shot (RDS) inhibits SARS-CoV, SARS-CoV-2 and Influenza A infection in vitro

Azithromycin trial fails to provide evidence of benefit in COVID-19

AI-based study of social media maps SARS-CoV-2 vaccine hesitancy across the US

Could wastewater surveillance help track SARS-COV-2 community outbreaks?

Tumor's stiff-arm tactic limits the effectiveness of immunotherapeutics

Trump’s wrong. 15% ‘herd immunity’ is not on par with strength of a vaccine

Structural inequalities in Brazil linked to higher COVID-19-related mortality in low-income areas

Researchers develop new technology for efficient production of monoclonal antibodies

Antibodies eBook

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest Life Science News